UK IBD Registry
- Local data to manage their biologics patients and IBD service more effectively
- The chance to be part of a national audit of the safety and appropriate use of biologics and biosimilars
In time the Registry will become a unique resource for real-world clinical effectiveness and health economic studies in IBD care. The aims for 2016/17 are:
- Transfer data collection to the IBD Registry from the RCP biological therapy audit web tool, which will be closing
- Develop a near-complete UK Register of IBD patients on biologics by the end of 2017
Find out more about…
A series of half-day meetings to support clinical teams as they join the IBD Registry. The sessions provide protected time for teams to learn about the Biologics Audit and QI programme using the IBD Registry, and to develop local plans…
The RCP audit now has closed so you need to export your data if you haven’t already done so. A data visualisation module for the Registry Web Tool will be piloted soon. NHS England has included the IBD Registry Biologics Audit on the Quality Accounts list for the coming year.
Audit & Registry – where next?
The UK IBD Registry:
Driving excellence with the IBD Registry
Dr Barney Hawthorne on IBD Registry as an opportunity for UK to be world-leading